ArticleAmerican journal of ophthalmology2022

Visual Field Endpoints for Neuroprotective Trials: A Case for AI-Driven Patient Enrichment.

Andrew Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.